Sanofi India board in its meeting held on July 27 had approved a transaction for slump sale and transfer of its nutraceuticals business to Universal Nutriscience for a consideration of Rs 587 crore.from Stocks-Markets-Economic Times https://ift.tt/3pzIPJ8
0 Comments:
Post a Comment